Coffee Grounds’ Role in Alzheimer’s and Parkinson’s Treatment

This news has been read 899 times!

KUWAIT CITY, Nov 24: A recent investigation suggests that coffee grounds may offer a novel therapeutic approach for Alzheimer’s and Parkinson’s diseases. The study demonstrates that carbon dots derived from caffeic acid (CACQDs), obtained from ground coffee, exhibit the capability to shield brain cells from damage associated with various neurodegenerative conditions triggered by factors like obesity, age, exposure to pesticides, and other environmental toxins.

In laboratory experiments, CACQDs proved effective in mitigating the impact of Parkinson’s disease induced by an insecticide called paraquat. The researchers envision the potential use of this treatment for individuals in the early stages of dementia and as a means to impede the progression of these diseases.

Jyotish Kumar, the lead author from the University of Texas at El Paso, emphasizes the transformative potential of CACQDs in addressing neurodegenerative disorders. Current treatments manage symptoms but do not provide a cure, and the researchers aspire to develop a treatment that targets the atomic and molecular factors underlying these conditions.

The manufacturing process involves heating ground coffee samples at 200 degrees Celsius for four hours to alter the carbon structure of caffeic acid, resulting in the creation of CACQDs. These carbon dots exhibited the capacity to eliminate free radicals, molecules associated with various conditions, including Parkinson’s disease, in test tube experiments, thereby preventing them from causing harm.

Moreover, the compound demonstrated the ability to hinder the accumulation of amyloid proteins linked to Alzheimer’s disease, with minimal observed side effects according to the researchers.

This news has been read 899 times!